Revolution Medicines (NASDAQ:RVMD) Price Target Lowered to $64.00 at Stifel Nicolaus
Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective cut by Stifel Nicolaus from $78.00 to $64.00 in a research report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Several other research firms have also recently weighed in on RVMD. Guggenheim upped their price objective on Revolution Medicines from […]
Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective cut by Stifel Nicolaus from $78.00 to $64.00 in a research report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Several other research firms have also recently weighed in on RVMD. Guggenheim upped their price objective on Revolution Medicines from […]